Design-Zyme LLC

ViroVax, LLC is a research-focused company based in Lawrence, KS, specializing in the development of innovative solutions in the field of virology. With a strong emphasis on research and publications, ViroVax is dedicated to advancing scientific knowledge and finding effective ways to combat viral diseases. Driven by a commitment to excellence, ViroVax, LLC aims to make significant contributions to the field of virology through their cutting-edge research and publications. Located at 2029 Becker Dr., Lawrence, KS 66047, ViroVax is at the forefront of scientific advancements in the fight against viral infections.Generated from the website

HylaPharm is a university spinout company based in Lawrence, Kansas, focused on developing innovative cancer therapies that have shown promising immune responses in real cancers in pet dogs. Their mission is to reverse tumor-induced immune suppression, enhancing the effectiveness of treatments for both animals and humans, particularly in fortifying responses to checkpoint inhibitors. The company has made significant progress, including the successful treatment of pet dogs with mast cell cancer and the acquisition of multiple grants to support their research initiatives. With a dedicated team based at the BTBC incubator, HylaPharm is at the forefront of cancer research and treatment advancement in both veterinary and human medicine. Generated from the website

Located in Lawrence, Kansas, Clara Biotech, Inc. stands out for its exclusive platform capable of extracting pure, intact, viable exosomes from a wide range of biofluid sources. This cutting-edge technology positions Clara Biotech as a leader in the field, offering unique solutions for isolating exosomes effectively. At Clara Biotech, innovation and precision are at the core of their operations, enabling them to provide unmatched capabilities in extracting exosomes. With a dedication to advancing research and biotechnology, Clara Biotech's pioneering approach sets them apart in the scientific community, opening new possibilities for exosome extraction across various biofluid types. Generated using this place's available information